January 8, 2025 Warsaw, Poland
Dear Colleagues,
We are delighted to welcome you to Warsaw for three days of stimulating sessions designed to spark new opportunities for collaborative research. The 6th Brain Tumor: from biology to therapy 2025 will unite the brightest minds in neuro oncology field to discuss, debate some of the greatest issues in the field and foster the development of international and inter-disciplinary collaborations supporting better understanding of the etiology, biology, outcomes and prevention of brain tumors. The conference will provide an excellent opportunity for clinicians, neuroscientists, neuro-oncologists, Pls, postdocs, PhD students to meet, present and discuss their work, build informal networks and set up new collaborations. Our multidisciplinary program combines expertise from across the breadth of brain tumor research, with focus on tumor immunology and immunotherapy together with insights from allied disciplines, to provide attendees with the innovative tools and techniques to apply to their own research. Internationally renowned speakers agreed to present their newest data on these topics. Abstracts for oral and poster presentations are invited and the best presentations will be awarded a prize. We expect exciting scientific exchange and invite you to join this meeting.
See You in Warsaw
Prof. Bozena Kaminska
Chair of the Organizing Committee
Plenary speakers:
Mariella Filbin, Dana-Farber Boston Children's Cancer and Blood Disorders Center | Broad Institute of Harvard and MIT, USA
Antonio Chiocca, Brigham and Women's Hospital Harvard Medical School, USA
Maria Castro, University of Michigan, USA
Speakers:
Ido Amit, Weizmann Institute of Science, Israel
Paolo Decuzzi, Italian Institute of Technology, Italy
Peter Dirks, University of Toronto | The Hospital for Sick Children, Canada
Dinorah Friedmann-Morvinski, Tel Aviv University, Israel
Florent Ginhoux, Institut Gustave Roussy, France
Dolores Hambardzumyan, Icahn School of Medicine at Mount Sinai, USA
Christel Herold-Mende, University Hospital Heidelberg, Germany
Chris Jones, Institute of Cancer Research, UK
Bozena Kaminska, Nencki Institute, Poland
Pedro Lowenstein, University of Michigan, USA
Duane Mitchell, University of Florida, USA
Michael Platten, German Cancer Research Center (DKFZ), Germany
Steven Pollard, University of Edinburgh, UK
Felix Sahm, University Hospital Heidelberg | German Cancer Research Center (DKFZ), Germany
Ronit Satchi-Fainaro, Tel Aviv University, Israel
Lisa Sevenich, German Cancer Consortium (DKTK) | Frankfurt Cancer Institute, Germany
Mario Suva, Broad Institute of Harvard and MIT | Massachusetts General Hospital and Harvard Medical School, USA
Lene Urhbom, Uppsala University, Sweden
Manuel Valiente, Spanish National Cancer Research Centre (CNIO), Spain